Jones, A;
Cotton, A;
Guinto, J;
Wilton, J;
Ciurtin, C;
(2018)
Outcome measures of disease activity for rare autoimmune rheumatic diseases.
British Journal of Hospital Medicine
, 79
(7)
pp. 396-401.
10.12968/hmed.2018.79.7.396.
Preview |
Text
Ciurtin_Outcomes paper.pdf - Accepted Version Download (603kB) | Preview |
Abstract
Systemic lupus erythematosus, scleroderma, myositis and Sjögren's syndrome are rare, complex, multi-systemic rheumatic diseases associated with significant morbidity and mortality. Thorough assessments of disease activity are required to guide clinical management and assess response to new therapies in clinical trials. This article reviews the commonly used outcome measures to assess this group of diseases and discusses the limitations of their use.
| Type: | Article |
|---|---|
| Title: | Outcome measures of disease activity for rare autoimmune rheumatic diseases |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.12968/hmed.2018.79.7.396 |
| Publisher version: | https://doi.org/10.12968/hmed.2018.79.7.396 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10045492 |
Archive Staff Only
 |
View Item |
